AJSP2601 - CME/CMLE - Loss of SATB2 in colorectal cancer is associated with inferior survival and adverse clinicopathological features: a meta-analysis
Course Description

This AJCP article offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements. The article has been published open access and is freely accessible here. 

Upon completion of this activity, learners will be able to: 

  1. Summarize key aspects of SATB2: its expression and distribution in normal tissues, its biological role, and effects of SATB2 absence on congenital abnormalities and developmental disorders. 

  1. Describe the impact of SATB2 expression or loss in colonic adenocarcinomas on survival, staging, and disease-free survival. 

  1. List mutations and histological features seen in colonic adenocarcinomas that have lost expression of SATB2. 

 

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants 


Faculty/Authors

Melissa P. Upton, MD

CME/CMLE Credit: 1.0
Estimated Completion Time: 1 hour
Format: Online Educational Activity and Post-Test

Physician Competencies: Medical knowledge, patient care, practice-based learning

Eligibility for CME/CMLE credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

  • Module ≥80% = CME credit
  • Module <80% = No CME credit, after a maximum of three attempts

Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME or SAMs CME credit.)

Accreditation Statement:
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Course to view an overview of the modules in this course.
  3. Click Access to begin the course.
  4. Review the Educational Activity.
  5. Complete and submit the Post-Test. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  6. Submit the course Evaluation to register your credit.

Faculty Disclosures​
The Journal CME editor and faculty have no relevant financial relationships with commercial interests to disclose.

Technical Considerations

Release Date: 3/23/2026 
Review Date:
Expiration Date: 3/23/2029 

Course Objectives
Following completion of this activity, you will be able to:
  • Summarize key aspects of SATB2: its expression and distribution in normal tissues, its biological role, and effects of SATB2 absence on congenital abnormalities and developmental disorders.  

  • Describe the impact of SATB2 expression or loss in colonic adenocarcinomas on survival, staging, and disease-free survival.  

  • List mutations and histological features seen in colonic adenocarcinomas that have lost expression of SATB2. 

Summary
Availability:
On-Demand
Credit Offered:
1 CME/CMLE Credit
Powered By